Key facts
- H2WIN’s last known valuation is $33.6M (Sep 2025).
- It has raised $7.0M; the latest was Later Stage VC ($1.5M) in Sep 2025.
- Notable investors include Harald Swenden, Jean-Marc Grison, Walloon Region.
- Status: Privately Held (backing).
- ·The complete investor list — 3 names
- ·Watchlist + deal alerts for H2WIN
- ·The full record, as it builds
Funding rounds
No funding rounds for H2WIN are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About H2WIN
Developer of a biocatalyst technology system designed for hydrogen production and energy conversion. The company facilitates the development of enzymatic systems from renewable sources using the biomimicry principles dedicated to industrial applications and to the hydrogen economy, enabling people to produce hydrogen from the direct conversion of sunlight and water with (photo)enzymatic catalysts.
- Sector
- Business Products and Services (B2B)
- HQ
- Nivelles, Belgium
- Founded
- 2013
- Employees
- 8
- Website
- h2win.com/
- Ownership
- Privately Held (backing)
H2WIN doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in H2WIN shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on H2WIN in its N-PORT filings yet. We sweep new filings monthly.